Track topics on Twitter Track topics that are important to you
Shares of Atossa Genetics were up over 368 percent on Thursday to close at US$7.07 following the approval from the FDA.
The post Atossa Genetics Soars on FDA Expanded Access Program Approval appeared first on Investing News Network.
Original Article: Atossa Genetics Soars on FDA Expanded Access Program ApprovalNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...